The role of TLRs (microbe recognition receptor) in gastric cancer: An update

Saade Abdalkareem Jasim1, Sumaya Ayad Abdulrazzaq2, H Malathi3

  • 1Medical Laboratory Techniques Department, Al-Maarif University College, Anbar, Iraq. saade.a.j@uoa.edu.iq.

Insights

Toll-like receptors (TLRs) play crucial roles in gastric cancer (GC) development by mediating immune responses and detecting danger signals. This review explores the multifaceted involvement of TLRs in GC pathogenesis and progression.

Area of Science:

  • Oncology
  • Immunology
  • Molecular Biology

Background:

  • Gastric cancer (GC) arises from complex interactions including genetic susceptibility, H. pylori infection, and environmental factors.
  • Gene mutations and epigenetic alterations disrupt molecular networks, affecting cell proliferation, apoptosis, and cell cycle regulation.
  • Toll-like receptors (TLRs) are key components of innate and adaptive immunity, recognizing pathogen-associated molecular patterns (PAMPs) and danger signals.

Purpose of the Study:

  • To review and compile the diverse roles of Toll-like receptors (TLRs) in the context of gastric cancer (GC).
  • To elucidate the involvement of TLRs in immune responses and molecular pathways relevant to GC development and progression.

Main Methods:

  • Comprehensive literature review of studies investigating TLRs in gastric cancer.
  • Analysis of research on TLR expression in both immune and malignant cells within the GC microenvironment.
  • Synthesis of findings on TLR-mediated recognition of PAMPs and danger signals in GC.

Main Results:

  • TLRs are expressed by both immune cells and gastric cancer cells.
  • TLRs recognize various PAMPs (e.g., CpG DNA, viral RNA, LPS) and danger-associated molecular patterns implicated in GC.
  • Dysregulation of TLR signaling contributes to the disruption of molecular networks in GC, impacting cell proliferation and apoptosis.

Conclusions:

  • Toll-like receptors are significantly implicated in the pathogenesis and progression of gastric cancer.
  • Understanding TLR functions in GC offers potential therapeutic targets for modulating immune responses and controlling cancer growth.

Related Concept Videos

Gastritis III: Clinical Manifestations and Management01:23

Gastritis III: Clinical Manifestations and Management

The clinical manifestations of gastritis can vary depending on the cause and type of gastritis, but some common symptoms may include the following.
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
110
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.4K
Gastritis-I: Introduction and Types01:27

Gastritis-I: Introduction and Types

Gastritis, defined by the inflammation or irritation of the stomach lining or gastric mucosa, manifests in several distinct forms: acute, chronic, reactive, and a specific subtype known as autoimmune metaplastic atrophic gastritis.
Acute gastritis presents as a sudden inflammation triggered by various stressors to the stomach lining, such as exposure to corrosive agents, local irritants like aspirin and other NSAIDs, alcohol consumption, radiation therapy, physical trauma, severe burns, sepsis,...
222
Gastritis-II: Pathophysiology01:17

Gastritis-II: Pathophysiology

Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
203
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.7K